Zacks Research Weighs in on Nutrien’s Q3 Earnings (NYSE:NTR)

Nutrien Ltd. (NYSE:NTRFree Report) – Stock analysts at Zacks Research increased their Q3 2026 earnings per share estimates for shares of Nutrien in a report released on Monday, May 25th. Zacks Research analyst Team now anticipates that the company will earn $0.92 per share for the quarter, up from their previous forecast of $0.91. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Nutrien’s current full-year earnings is $5.45 per share.

Nutrien (NYSE:NTRGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.48 by $0.03. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The firm’s quarterly revenue was up 18.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.11 EPS.

Several other equities research analysts have also issued reports on the stock. Royal Bank Of Canada lifted their price objective on shares of Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research note on Tuesday, April 7th. UBS Group reduced their price target on Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. Barclays increased their price objective on Nutrien from $70.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, March 3rd. Weiss Ratings lowered Nutrien from a “buy (b-)” rating to a “hold (c)” rating in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. upped their target price on Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Eleven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $82.75.

Read Our Latest Stock Analysis on Nutrien

Nutrien Stock Performance

NTR stock opened at $70.02 on Wednesday. The firm has a 50 day moving average of $73.46 and a two-hundred day moving average of $68.30. Nutrien has a 12 month low of $53.03 and a 12 month high of $85.36. The company has a market capitalization of $33.61 billion, a price-to-earnings ratio of 14.26, a P/E/G ratio of 0.64 and a beta of 0.64. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35.

Nutrien Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.55 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.1%. Nutrien’s payout ratio is 44.81%.

Institutional Investors Weigh In On Nutrien

Hedge funds and other institutional investors have recently modified their holdings of the stock. Guggenheim Capital LLC raised its stake in Nutrien by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after purchasing an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC increased its holdings in shares of Nutrien by 1.8% during the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after purchasing an additional 164 shares during the period. Banque Cantonale Vaudoise raised its position in shares of Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after buying an additional 164 shares during the last quarter. Gould Asset Management LLC CA lifted its stake in shares of Nutrien by 4.4% in the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after buying an additional 165 shares during the period. Finally, Smith Moore & CO. increased its stake in Nutrien by 2.2% during the third quarter. Smith Moore & CO. now owns 7,642 shares of the company’s stock valued at $449,000 after acquiring an additional 168 shares during the period. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Earnings History and Estimates for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.